October 24, 2021

Volume XI, Number 297

Advertisement
Advertisement

October 22, 2021

Subscribe to Latest Legal News and Analysis

October 21, 2021

Subscribe to Latest Legal News and Analysis
Advertisement

Japan is Contemplating the Future of Cell-based Meats

The Japanese food authorities have been actively deliberating food regulatory matters regarding how to better use new technologies to diversify protein sources for consumers. 

The Japanese food authorities have been actively deliberating food regulatory matters regarding how to better use new technologies to diversify protein sources for consumers. 

Alternative protein products, such as cell-based meat, are gaining attention given their unique advantages of offering additional sources of protein in the diet and their ability to promote a more sustainable food system. Supported by the Japanese Agriculture, Forestry and Fisheries (MAFF), a public-private partnership known as Food Tech Research Group was established in 2020 to develop strategies and policies regarding emerging food technologies; to no surprise, cell-based meat is on their agenda.

Currently, Japan has not promulgated any new food regulations or standards that explicitly address a regulatory framework for cell-based meat. However, the existing food legislation has stipulated some general requirements that are likely to apply. For instance, Article 3 of the Japanese Food Sanitation Act requires that a food business operator shall take necessary measures to ensure the safety of the food for sale for human consumption. 

Article 7 further states that articles that have "not generally been served for human consumption" and "have not been proven to involve no risk to human health" or "articles including those articles having newly come to be sold or are going to be sold as food," may be prohibited from being sold as foods by the Minister of Health, Labour and Welfare when the authority finds it necessary to prevent food sanitation hazards. Applying these basic requirements, the food industry will no doubt be obligated to properly assess and confirm the safety of cell-based meat before launching a product, and if the authority disagrees, it may challenge such safety conclusion. 

While there remains a lot to be seen in terms of the regulatory developments and requirements for cell-based meat in Japan, e.g., whether there will be an approval process like the one introduced by the Singaporean authority earlier this year, (See Keller and Heckman Newsletter for more details), the local authority appears to be open to engagement with stakeholders during the process of formulating the best approach to regulate cell-based products. Notably, MAFF has set forth a plan in this regard, such as setting up working groups to draft regulations and standards for "food-tech" proteins (e.g., cell-based meat, algal proteins, and insects for foods). Thus, it will be critical for industry to participate in the rule-making process and let its voice be heard to help shape the future of the regulatory landscape in Japan. One way to engage is to join associations and coalitions that are starting to form in Asia. In fact, a new industry association is being established in Asia Pacific which focuses on promoting cell-based meat, poultry, and seafoods. If you are interested, please contact David Ettinger at the email address below.

© 2021 Keller and Heckman LLPNational Law Review, Volume XI, Number 246
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement

About this Author

David J. Ettinger, Keller Heckman, Partner, Food and Drug Corporation, International Trade Lawyer, Attorney, Shanghai, China
Partner

David Ettinger joined Keller and Heckman in 1999. Mr. Ettinger represents domestic and foreign corporations in the area of food and drug law.

Mr. Ettinger relocated to Keller and Heckman's Shanghai office in November 2012 to focus on the Asian market and counsel companies in the Far East on food, drug, and chemical regulatory matters. He has extensive experience counseling clients on product development and product protection of food and drug packaging in the United States, Europe, Asia, Canada, and South America. From 2006-2007, Mr. Ettinger...

86 21-6335-1000
Jenny Li, Keller Heckman, China Food, Drug Regulation, Shanghai, International Trade
Legal Consultant

Jenny Li joined Keller and Heckman in October 2007.

Ms. Li counsels clients on regulatory issues focusing on food and drug, with an emphasis on regulatory regimes in the Asia-Pacific region. She also counsels clients on food labeling, food claims, food additives, as well as, important issues regarding food imports in Asian countries.

86-21-6335-1000
Advertisement
Advertisement
Advertisement